Faculty of Medicine, University of Valladolid, Valladolid, Spain.
National Influenza Center of Valladolid, Valladolid, Spain.
Sci Rep. 2024 Jan 3;14(1):353. doi: 10.1038/s41598-023-50335-6.
SARS-CoV-2 reinfections have been frequent, even among those vaccinated. The aim of this study is to know if hybrid immunity (infection + vaccination) is affected by the moment of vaccination and number of doses received. We conducted a retrospective study in 746 patients with a history of COVID-19 reinfection and recovered the dates of infection and reinfection and vaccination status (date and number of doses). To assess differences in the time to reinfection(t) between unvaccinated, vaccinated before 6 months, and later; and comparing one, two or three doses (incomplete, complete and booster regime) we performed the log-rank test of the cumulative incidence calculated as 1 minus the Kaplan-Meier estimator. Also, an adjusted Cox-regression was performed to evaluate the risk of reinfection in all groups. The t was significantly higher in those vaccinated vs. non-vaccinated (p < 0.001). However, an early incomplete regime protects similar time than not receiving a vaccine. Vaccination before 6 months after infection showed a lower t compared to those vaccinated later with the same regime (adj-p < 0.001). Actually, early vaccination with complete and booster regimes provided lower length of protection compared to vaccinating later with incomplete and complete regime, respectively. Vaccination with complete and booster regimes significantly increases the t (adj-p < 0.001). Vaccination increases the time it takes for a person to become reinfected with SARS-CoV-2. Increasing the time from infection to vaccination increases the time in which a person could be reinfected and reduces the risk of reinfection, especially in complete and booster regimes. Those results emphasize the role of vaccines and boosters during the pandemic and can guide strategies on future vaccination policy.
SARS-CoV-2 再感染很常见,即使是那些接种过疫苗的人也是如此。本研究旨在了解混合免疫(感染+接种)是否受接种时间和接种剂量数的影响。我们对 746 名有 COVID-19 再感染史的患者进行了回顾性研究,恢复了感染和再感染的日期以及疫苗接种状态(日期和接种剂量数)。为了评估未接种、接种时间在 6 个月之前和之后、以及比较一剂、两剂或三剂(不完全、完全和加强剂方案)之间再感染时间(t)的差异,我们计算了累积发生率的对数秩检验,该发生率作为 1 减去 Kaplan-Meier 估计值。此外,还进行了调整后的 Cox 回归分析,以评估所有组的再感染风险。与未接种疫苗的患者相比,接种疫苗的患者 t 值显著更高(p<0.001)。然而,早期接种不完全方案与未接种疫苗的保护时间相似。与感染后 6 个月内接种疫苗的患者相比,感染后 6 个月内接种疫苗的患者 t 值较低(调整后 p<0.001)。实际上,早期接种完全和加强剂方案与感染后接种不完全和完全方案相比,提供的保护时间更短。接种完全和加强剂方案可显著延长 t 值(调整后 p<0.001)。接种疫苗可延长 SARS-CoV-2 再感染的时间。从感染到接种疫苗的时间间隔越长,感染的时间就越长,再感染的风险就越低,尤其是在完全和加强剂方案中。这些结果强调了疫苗和加强剂在大流行期间的作用,并为未来的疫苗接种策略提供了指导。